Akros U.S. AI Software TOP4 Plus Index

Tempus AI is scheduled to report its Q2 2026 financial results; earnings releases typically result in price moves of 5% or more, scheduled.

AppLovin's Q2 2026 earnings release is expected around August 5, 2026, based on past reporting schedules expected. Low impact estimated as the announcement of a date typically precedes the actual market-moving results.

Oracle is scheduled to release its fourth quarter and full fiscal year 2026 financial results after the market close on June 10, 2026, with a conference call to follow. High importance is estimated as earnings releases typically result in significant price volatility, scheduled.

Annual Shareholder Meeting on 2026-06-04 scheduled.

Stock price fell 8% on June 2, 2026, following new product and partnership announcements at the company's annual Snowflake Summit event.

Fastly management is scheduled to participate in a presentation at the William Blair 46th Annual Growth Stock Conference; low impact is estimated as conference presentations typically provide incremental updates scheduled.

Citigroup reaffirmed its 'buy' rating on AppLovin stock with a price target of $710.00 forecasted. Low impact estimated as analyst rating reaffirmations generally result in minor market adjustments.

Tempus announced the upcoming clinical availability of its first whole-genome sequencing assay, xH, for hematologic malignancies.

Tempus announced the launch of the next-generation of Lens, its agentic AI platform for oncology drug development.

Oracle's stock price increased significantly following the announcement of a substantial cloud infrastructure agreement with the US government, positioning the company as a key provider of AI computing capacity for national security.

CTO Artur Bergman sold 6,225 shares to satisfy tax obligations related to the vesting of Restricted Stock Units (RSUs).

Tempus AI held its inaugural investor day, providing overviews of its Diagnostics and Data and Applications segments and financial expectations.

Figma announced a major update for its AI tool, Figma Make, on May 28, 2026, introducing a two-way integration with GitHub that allows users to visually edit production code from the Figma canvas.

At the 2026 Annual Meeting of Stockholders on May 28, 2026, the company's stockholders approved an amendment to the 2013 Equity Incentive Plan, increasing the number of shares reserved for issuance by 34 million. Low importance is assigned as this is a routine administrative update with minimal immediate market impact.

Activist investor Findell Capital Management issued a public letter to Figma's board on May 28, 2026, urging the company to streamline its product portfolio and review its relationship with AI company Anthropic.